Grants and Contributions

About this information

In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.

The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.

Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.

Found 2127 records

$469,404.00

Jul 1, 2016
Description:

Development of Gene Therapy for Autism Spectrum and other Neurodevelopmental Disorders

Organization: Canadian Institutes of Health Research
Location: Toronto, Ontario, CA M5S 1A1

$305,439.00

Nov 1, 2017
Description:

Mutation-targeted gene and pharmacological therapies for dystrophic and junctional Epidermolysis Bullosa

Organization: Canadian Institutes of Health Research
Location: Vancouver, British Columbia, CA V6T 1Z1

$293,267.00

Oct 1, 2011
Description:

Bone marrow-derived stem cell-based gene therapy to accelerate fracture healing

Organization: Canadian Institutes of Health Research
Location: Toronto, Ontario, CA M5B 1W8

$150,000.00

Jul 1, 2014
Description:

Combinatorial Gene Therapy for the Treatment of Early- and Late-Stage Osteoarthritis

Organization: Canadian Institutes of Health Research
Location: Houton, US

$225,000.00

Jul 1, 2024

For-profit organization

Agreement:

Development of a High Pressure Storage Solution for Cell Gene Therapy Applications

Agreement Number:

1022481

Duration: from Jul 1, 2024 to Mar 31, 2025
Description:

Develop a high pressure system for use in Cell Gene Therapy applications.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Contributions to Firms
Location: Nepean, Ontario, CA K2E 7S8

$105,000.00

May 1, 2016
Description:

A Novel Approach to Gene Therapy for the Treatment of Spinal Muscular Atrophy

Organization: Canadian Institutes of Health Research
Location: Ottawa, Ontario, CA K1Y 4E9

$975,375.00

Apr 1, 2017
Description:

An "Inducible" Gene Therapy for Glaucoma: A Novel Approach to Prevent Loss of Vision

Organization: Canadian Institutes of Health Research
Location: Vancouver, British Columbia, CA V6T 1Z1

$110,000.00

Apr 1, 2012
Description:

Ex Vivo IL-10 Gene Therapy in a Pre-Clinical Lung Transplantation Survival Model

Organization: Canadian Institutes of Health Research
Location: Toronto, Ontario, CA M5G 2C4

$250,468.00

Oct 1, 2014
Description:

Cochlear gene therapy targeting the protection against aging related hearing loss and neuronal degeneration

Organization: Canadian Institutes of Health Research
Location: Halifax, Nova Scotia, CA B3H 3J5

$150,000.00

Sep 1, 2016
Description:

"Kill-switch" enabled, immune-silent, non-cytopathic, and persistent paramyxovirus vector for respiratory gene therapy.

Organization: Canadian Institutes of Health Research
Location: New York, US